11/20/2026 | Press release | Distributed by Public on 11/21/2026 11:38
(WASHINGTON, D.C.) - Consumer Healthcare Products Association (CHPA) President & CEO Scott Melville released the following statement today regarding New York Governor Kathy Hochul's decision to veto A1556G/S1239F, the Food Safety and Chemical Disclosure Act:
"CHPA appreciates Governor Hochul's recognition of the importance of protecting New York consumers from higher costs while maintaining strong, science-based safety standards.
"As we emphasized throughout the legislative process, additional state-level requirements could create unnecessary compliance costs and regulatory uncertainty, with potential implications for the affordability and accessibility of everyday self-care products, including dietary supplements.
"We also share the governor's emphasis on strong federal oversight. A consistent, science-based national regulatory framework is essential to protecting consumers while avoiding a patchwork of conflicting state requirements that could increase costs and limit access.
"CHPA looks forward to working with policymakers at both the state and federal levels to advance consumer affordability, and access to self-care products."
The Consumer Healthcare Products Association (CHPA), founded in 1881, is the national trade association representing the leading manufacturers and marketers of consumer healthcare products, including over-the-counter (OTC) medicines, dietary supplements, and OTC medical devices. CHPA is committed to empowering self-care by ensuring that Americans have access to products they can count on to be reliable, affordable, and convenient, while also delivering new and better ways to get and stay healthy. Visit www.chpa.org.